Liraglutide

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5503 publications

Comparison of pharmacotherapies for obesity with sleeve gastrectomy: a network meta-analysis and systematic review.

Comparison of pharmacotherapies for obesity with sleeve gastrectomy: a network meta-analysis and systematic review.

Journal: Expert review of endocrinology & metabolism

Published: April 13, 2026

The Therapeutic Potential of Glucagon-Like Peptide-1 Receptor Agonists in Psoriasis and Hidradenitis Suppurativa.

The Therapeutic Potential of Glucagon-Like Peptide-1 Receptor Agonists in Psoriasis and Hidradenitis Suppurativa.

Journal: The Journal of clinical and aesthetic dermatology

Published: March 27, 2026

Weight Changes With Tirzepatide and Concomitant Weight-Inducing Medications: Post Hoc Analysis of Randomized Clinical Trials.

Weight Changes With Tirzepatide and Concomitant Weight-Inducing Medications: Post Hoc Analysis of Randomized Clinical Trials.

Journal: JAMA network open

Published: March 26, 2026

Joint TOS/OMA/OAC expert guidance statement on the pharmacological management of United States adults with overweight or obesity using the GRADE approach.

Joint TOS/OMA/OAC expert guidance statement on the pharmacological management of United States adults with overweight or obesity using the GRADE approach.

Journal: Obesity pillars

Published: March 20, 2026

Impact of Liraglutide on Insulin Clearance in Patients with Type 2 Diabetes Mellitus: Evidence from a Randomized Controlled Trial.

Impact of Liraglutide on Insulin Clearance in Patients with Type 2 Diabetes Mellitus: Evidence from a Randomized Controlled Trial.

Journal: Diabetes & metabolism journal

Published: March 11, 2026

Oral Delivery of Liraglutide Formulated with PLGA for Sustained Obesity Management.

Oral Delivery of Liraglutide Formulated with PLGA for Sustained Obesity Management.

Journal: International journal of molecular sciences

Published: March 09, 2026

Obesity: novel pharmacological treatments

Obesity: novel pharmacological treatments

Journal: Deutsche medizinische Wochenschrift (1946)

Published: March 09, 2026

Heterogeneity of Treatment Effects of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in Adults: A Systematic Review and Meta-Analysis.

Heterogeneity of Treatment Effects of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in Adults: A Systematic Review and Meta-Analysis.

Journal: JAMA internal medicine

Published: March 02, 2026

Disproportionality Analysis of Tirzepatide vs. Semaglutide and Liraglutide: System Organ Class-Level Post-Marketing Reporting Patterns in EudraVigilance.

Disproportionality Analysis of Tirzepatide vs. Semaglutide and Liraglutide: System Organ Class-Level Post-Marketing Reporting Patterns in EudraVigilance.

Journal: International journal of molecular sciences

Published: February 26, 2026

Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation.

Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation.

Journal: Circulation

Published: February 24, 2026

Weight regain after bariatric surgery: A framework for management.

Weight regain after bariatric surgery: A framework for management.

Journal: JAAPA : official journal of the American Academy of Physician Assistants

Published: February 24, 2026

Hyperglycemia promotes maladaptive Dectin-1 signaling and impairs skin antifungal host defense.

Hyperglycemia promotes maladaptive Dectin-1 signaling and impairs skin antifungal host defense.

Journal: bioRxiv : the preprint server for biology

Published: February 23, 2026

Showing 1-12 of 5,503

Last Updated: 04/28/2026